Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors

Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors

US Patent 11453673 · Granted Sep 27, 2022

Estimated economic value: $750,369,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of the menin-MLL interaction2024
[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes2022
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
Compounds useful for inhibiting RORγt2021
Compounds useful for inhibiting ROR-gamma-t2020
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2019
Bicyclic heteroaryl amine compounds2019
Triazolopyrazinone derivative useful as a human PDE1 inhibitor2018
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2018
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors2018
Tricyclic sulfones as RORγ modulators2017